Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001829049-21-000001
Filing Date
2021-08-05
Accepted
2021-08-05 14:45:16
Documents
1
Effectiveness Date
2021-08-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8349
  Complete submission text file 0001829049-21-000001.txt   9427
Mailing Address 12770 HIGH BLUFF DRIVE SUITE 380 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE SUITE 380 SAN DIEGO CA 92130 858-987-4064
Aristea Therapeutics, Inc. (Filer) CIK: 0001829049 (see all company filings)

EIN.: 831074231 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-378342 | Film No.: 211147603